The EasyScreenTM SARS-CoV-2 Detection Kit in conjunction with the Company’s highest throughput instrument, GS-1000, provides laboratories the ability to process approximately 1,500 samples per instrument in a 24-hour period. As more sequencing of the SARS-CoV-2 virus is published it is apparent that the viral mutations are occurring and there are at least 8 different strains already identified1. Genetic Signatures’ 3baseTM platform technology was invented in order to recognise common nucleic acid mutations.